Kura Oncology (KURA) stock Forecast for 2021 – 2025

Kura Oncology (KURA) stock Forecast for 2022 – 2026

Last update: 05-19-2022, 17:07

Sector: Healthcare

The share price of Kura Oncology, Inc. (KURA) now

What analysts predict:: $35.88

52-week high/low: $24.59 / $10.41

50/200 Day Moving Average: $15.16 / $15.94

This figure corresponds to the average price over the previous 50/200 days. For Kura Oncology stocks, the 50-day moving average is the resistance level today.

For Kura Oncology stocks, the 200-day moving average is the resistance level today.

Are you interested in Kura Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Kura Oncology stock price in 2022, 2023, 2024, 2025, 2026. How much will one Kura Oncology share be worth in 2022 - 2026?

When should I take profit in Kura Oncology stock? When should I record a loss on Kura Oncology stock? What are analysts' forecasts for Kura Oncology stock? What is the future of Kura Oncology stock?

We forecast Kura Oncology stock performance using neural networks based on historical data on Kura Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Kura Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Kura Oncology shares. This happens once a day.




Historical and forecast chart of Kura Oncology stock

The chart below shows the historical price of Kura Oncology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Kura Oncology stock price can be found in the table below.

Long-term forecasts by years.

Kura Oncology daily forecast for a month

Date Target Pes. Opt. Vol., %
May 21 12.04 11.94 12.10 1.36
May 22 12.04 11.91 12.24 2.78
May 23 11.86 11.70 12.02 2.68
May 24 11.99 11.92 12.09 1.43
May 25 12.09 11.97 12.24 2.27
May 26 12.35 12.27 12.44 1.36
May 27 12.23 12.15 12.38 1.96
May 28 12.19 11.95 12.33 3.21
May 29 12.40 12.16 12.55 3.19
May 30 12.40 12.23 12.48 2.00
May 31 12.29 12.05 12.37 2.60
Jun 01 12.18 11.97 12.32 2.98
Jun 02 12.17 11.96 12.31 2.93
Jun 03 12.12 11.97 12.29 2.68
Jun 04 12.28 12.19 12.46 2.19
Jun 05 12.20 12.00 12.36 3.03
Jun 06 12.50 12.41 12.62 1.66
Jun 07 12.61 12.46 12.73 2.20
Jun 08 12.39 12.22 12.57 2.84
Jun 09 12.25 12.07 12.45 3.17
Jun 10 12.15 11.95 12.22 2.24
Jun 11 12.15 12.00 12.38 3.16
Jun 12 12.45 12.29 12.68 3.19
Jun 13 12.68 12.47 12.91 3.48
Jun 14 12.83 12.59 13.00 3.24
Jun 15 12.96 12.71 13.16 3.57
Jun 16 12.89 12.73 13.14 3.21
Jun 17 12.62 12.43 12.83 3.17
Jun 18 12.76 12.51 12.95 3.54
Jun 19 12.63 12.50 12.70 1.59

Kura Oncology Daily Price Targets


Kura Oncology Stock Forecast 05-21-2022.

Forecast target price for 05-21-2022: $12.04. Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.343%.

Pessimistic target level: 11.94

Optimistic target level: 12.10


Kura Oncology Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $12.04. Positive dynamics for Kura Oncology shares will prevail with possible volatility of 2.706%.

Pessimistic target level: 11.91

Optimistic target level: 12.24


Kura Oncology Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $11.86. Negative dynamics for Kura Oncology shares will prevail with possible volatility of 2.614%.

Pessimistic target level: 11.70

Optimistic target level: 12.02


Kura Oncology Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $11.99. Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.413%.

Pessimistic target level: 11.92

Optimistic target level: 12.09


Kura Oncology Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $12.09. Positive dynamics for Kura Oncology shares will prevail with possible volatility of 2.223%.

Pessimistic target level: 11.97

Optimistic target level: 12.24


Kura Oncology Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $12.35. Positive dynamics for Kura Oncology shares will prevail with possible volatility of 1.339%.

Pessimistic target level: 12.27

Optimistic target level: 12.44


KURA (KURA) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 12.40 11.32 13.25 14.59
Jul. 12.02 11.45 12.76 10.29
Aug. 11.96 11.42 13.00 12.20
Sep. 12.46 11.80 13.04 9.56
Oct. 11.96 11.65 12.58 7.41
Nov. 11.74 10.61 12.59 15.75
Dec. 11.72 11.24 12.06 6.83

Kura Oncology forecast for this year


Kura Oncology Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $12.3952. Pessimistic: $11.32. Optimistic: $13.25


Kura Oncology Stock Prediction for Jul 2022

An downtrend is forecast for this month with an optimal target price of $12.0246. Pessimistic: $11.45. Optimistic: $12.76


Kura Oncology Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $11.9621. Pessimistic: $11.42. Optimistic: $13.00


Kura Oncology Stock Prediction for Sep 2022

An uptrend is forecast for this month with an optimal target price of $12.4597. Pessimistic: $11.80. Optimistic: $13.04


Kura Oncology Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $11.9576. Pessimistic: $11.65. Optimistic: $12.58


Kura Oncology Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $11.7399. Pessimistic: $10.61. Optimistic: $12.59


Kura Oncology Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $11.7247. Pessimistic: $11.24. Optimistic: $12.06




Kura Oncology (KURA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 12.14 11.58 12.64 8.36
Feb 11.55 10.94 12.41 11.86
Mar 10.56 10.29 10.93 5.90
Apr 10.05 9.27 11.01 15.79
May 9.20 8.76 9.49 7.69
Jun 9.19 8.63 9.73 11.30
Jul 8.75 8.16 9.50 14.13
Aug 9.67 9.34 10.30 9.28
Sep 9.82 9.04 10.27 11.94
Oct 9.89 9.32 10.73 13.17
Nov 11.09 10.32 11.90 13.33
Dec 10.63 10.11 11.56 12.56

Kura Oncology (KURA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 10.25 9.25 11.02 16.08
Feb 10.91 9.85 11.92 17.38
Mar 11.00 10.68 12.03 11.17
Apr 11.15 10.28 12.07 14.78
May 10.76 10.31 11.67 11.63
Jun 11.08 10.18 11.78 13.58
Jul 12.06 11.25 12.75 11.81
Aug 13.00 12.26 13.85 11.47
Sep 13.26 12.09 14.36 15.84
Oct 13.22 11.99 14.13 15.20
Nov 13.52 13.06 14.87 12.17
Dec 12.76 11.72 13.37 12.40



Kura Oncology (KURA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 12.35 11.93 12.70 6.07
Feb 12.38 12.06 12.75 5.43
Mar 11.96 10.87 13.06 16.78
Apr 13.00 12.22 13.61 10.18
May 12.16 11.37 13.06 12.95
Jun 13.33 12.93 14.04 7.90
Jul 12.88 12.19 13.63 10.56
Aug 13.78 12.61 14.62 13.72
Sep 13.46 12.90 14.17 9.01
Oct 14.03 13.38 15.16 11.79
Nov 14.11 13.12 14.58 10.06
Dec 13.24 12.76 13.97 8.63

Kura Oncology (KURA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 13.49 12.29 14.47 15.03
Feb 12.84 12.42 13.34 6.88
Mar 14.09 13.45 15.28 11.99
Apr 13.17 12.64 14.25 11.30
May 12.59 11.58 13.43 13.78
Jun 12.93 11.82 14.13 16.31
Jul 14.11 13.01 15.32 15.09
Aug 15.23 14.52 16.72 13.15
Sep 13.75 12.69 14.50 12.45
Oct 13.78 13.35 14.39 7.22
Nov 13.78 12.65 14.93 15.24
Dec 12.20 11.62 13.32 12.75

Kura Oncology information and performance

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Kura Oncology Address

3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA, US

Market Capitalization: 800 300 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -63 452 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.966

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 66636000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.